Zumutor Biologics retweeted
We are excited to share that Zumutor Biologics in partnership with Prof Shiladitya Sengupta of Harvard Med has been shortlisted by USIST Endowment Board for development of monoclonal antibody therapeutics for COVID 19.
#COVID19
#therapeutics
Zumutor Biologics retweeted
I am not very familiar with this philosophy but you don’t need a Ph.D in the subject to see the common sense in this prescription for life. A good chart to see every morning before plunging into the day’s routine...
Zumutor Biologics retweeted
Zumutor has been listed as one of the watch out start-up in healthcare in 2020.
inc42.com/features/startup-w…
Zumutor Biologics retweeted
We have been nominated as 25 most disruptive Indian startups....we do innovative science
#immunotherapy
#immuno_oncology gadgetsnow.com/slideshows/25…
Zumutor Biologics retweeted
Kavita Iyer Rodrigues, CCAMP startup @zumutor discusses the reasons for long pipeline in technology development & why good investors are a must for any company to be successful.
Kavita is a @NITIAayog #WTIawards2019 winner & in the run for @EconomicTimes Top Innovator award 2019
Zumutor Biologics retweeted
Here's also a look at the nominees of Top innovator category for #ETStartupAwards2019 👉@niramaianalytix @stellapps @tricoghealth @carbonsolu @zumutor
tech.economictimes.indiatime…






